![Phase I/II study of weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small-cell lung cancer: Kansai Clinical Oncology Group T0401 Phase I/II study of weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small-cell lung cancer: Kansai Clinical Oncology Group T0401](https://www.oatext.com/img/IMM-4-300-g001.gif)
Phase I/II study of weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small-cell lung cancer: Kansai Clinical Oncology Group T0401
![Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review | Semantic Scholar Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1bcfdfb6a0fd7f6728b02d83649beaa6bfe37c20/2-Table1-1.png)
Analysis of carboplatin dosing in patients with a glomerular filtration rate greater than 125 mL/min: To cap or not to cap? A retrospective analysis and review | Semantic Scholar
![Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | SpringerLink Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-020-05868-z/MediaObjects/10549_2020_5868_Fig1_HTML.png)
Carboplatin dose capping affects pCR rate in HER2-positive breast cancer patients treated with neoadjuvant Docetaxel, Carboplatin, Trastuzumab, Pertuzumab (TCHP) | SpringerLink
![Evaluation of the impact of treatment delays and dose reductions in human ovarian cancer orthotopic mouse models Evaluation of the impact of treatment delays and dose reductions in human ovarian cancer orthotopic mouse models](https://www.oatext.com/img/ICST-2-155-1.jpg)
Evaluation of the impact of treatment delays and dose reductions in human ovarian cancer orthotopic mouse models
![Evaluation of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (C-G) formulas in the Calvert equation for Carboplatin Dosing Whitney. - ppt video online download Evaluation of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (C-G) formulas in the Calvert equation for Carboplatin Dosing Whitney. - ppt video online download](https://slideplayer.com/slide/5736905/19/images/2/Background+Carboplatin+is+a+second+generation+platinum+agent.jpg)
Evaluation of the Modification of Diet in Renal Disease (MDRD) and Cockcroft-Gault (C-G) formulas in the Calvert equation for Carboplatin Dosing Whitney. - ppt video online download
![Evaluation of the Modified Diet in Renal Disease Equation for Calculation of Carboplatin Dose | Semantic Scholar Evaluation of the Modified Diet in Renal Disease Equation for Calculation of Carboplatin Dose | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cda54e825ed293da72a425da0cc2a5562bc7c428/2-Table1-1.png)
Evaluation of the Modified Diet in Renal Disease Equation for Calculation of Carboplatin Dose | Semantic Scholar
![Evaluation of glomerular filtration rate estimation by Cockcroft–Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients - Annals of Oncology Evaluation of glomerular filtration rate estimation by Cockcroft–Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/f189f74e-04da-4efc-957f-29fa1741bca1/gr1.jpg)
Evaluation of glomerular filtration rate estimation by Cockcroft–Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients - Annals of Oncology
![Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom - Barnett - 2021 - British Journal of Clinical Pharmacology - Wiley Online Library Over a decade of experience with carboplatin therapeutic drug monitoring in a childhood cancer setting in the United Kingdom - Barnett - 2021 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/1c1fcff5-b575-4a62-8717-8a293eeca62b/bcp14419-fig-0001-m.jpg)